← Open Payments lookup

SARAH KELLER: Open Payments

NPI 1548732894 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,916 in 110 payments from 12 companies in 2025. Trend: 2023 $1,950 · 2024 $2,037 · 2025 $1,916

Food & beverage: $1,916
CompanyPaymentsAmount
ABBVIE INC.56$760
Janssen Biotech, Inc.21$531
Takeda Pharmaceuticals U.S.A., Inc.10$222
Salix Pharmaceuticals, a division of Bausch Health US, LLC6$124
Lilly USA, LLC4$61
Aimmune Therapeutics, Inc.3$56
Madrigal Pharmaceuticals2$47
Ardelyx, Inc.3$46
Novo Nordisk Inc1$23
Gilead Sciences, Inc.1$20

Products named: RINVOQ, TREMFYA, ENTYVIO, XIFAXAN, SKYRIZI, CREON, ZENPEP, REZDIFFRA.

Industry payments across KY — which companies pay providers there.